SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-22-012650
Filing Date
2022-12-19
Accepted
2022-12-19 07:08:15
Documents
1
Period of Report
2022-11-25

Document Format Files

Seq Description Document Type Size
1 form4a-12192022_121206.html 4/A  
1 form4a-12192022_121206.xml 4/A 7238
  Complete submission text file 0001415889-22-012650.txt   8695
Mailing Address 12 HARVEY DRIVE SHORT HILLS NJ 07078
Business Address
VAN VOORHEES SETH (Reporting) CIK: 0001284934 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38302 | Film No.: 221469597

Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations